Clinical Trial Update: First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 randomized trial in advanced bladder cancer comparing first-line gemcitabine with versus without vinflunine in patients ineligible for cis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vinflunine (vinflunine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Bladder Cancer, Transitional Cell Carcinoma | Phase 2, Phase 3 | Status: COMPLETED